Literature DB >> 17014846

Axon regeneration through scars and into sites of chronic spinal cord injury.

Paul Lu1, Leonard L Jones, Mark H Tuszynski.   

Abstract

Cellular and extracellular inhibitors are thought to restrict axon growth after chronic spinal cord injury (SCI), confronting the axon with a combination of chronic astrocytosis and extracellular matrix-associated inhibitors that collectively constitute the chronic "scar." To examine whether the chronically injured environment is strongly inhibitory to axonal regeneration, we grafted permissive autologous bone marrow stromal cells (MSCs) into mid-cervical SCI sites of adult rats, 6 weeks post-injury without resection of the "chronic scar." Additional subjects received MSCs genetically modified to express neurotrophin-3 (NT-3), providing a further local stimulus to axon growth. Anatomical analysis 3 months post-injury revealed extensive astrocytosis surrounding the lesion site, together with dense deposition of the inhibitory extracellular matrix molecule NG2. Despite this inhibitory environment, axons penetrated the lesion site through the chronic scar. Robust axonal regeneration occurred into chronic lesion cavities expressing NT-3. Notably, chronically regenerating axons preferentially associated with Schwann cell surfaces expressing both inhibitory NG2 substrates and the permissive substrates L1 and NCAM in the lesion site. Collectively, these findings indicate that inhibitory factors deposited at sites of chronic SCI do not create impenetrable boundaries and that inhibition can be balanced by local and diffusible signals to generate robust axonal growth even without resecting chronic scar tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17014846     DOI: 10.1016/j.expneurol.2006.07.030

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  58 in total

1.  Glial Cell Line-Derived Neurotrophic Factor-Transfected Placenta-Derived Versus Bone Marrow-Derived Mesenchymal Cells for Treating Spinal Cord Injury.

Authors:  Yao Lu; Hui Gao; Man Zhang; Bing Chen; Huilin Yang
Journal:  Med Sci Monit       Date:  2017-04-14

Review 2.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

3.  Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice.

Authors:  Xiaoyun Xu; Nicole Geremia; Feng Bao; Anna Pniak; Melissa Rossoni; Arthur Brown
Journal:  Cell Transplant       Date:  2010-11-19       Impact factor: 4.064

4.  Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.

Authors:  James M Massey; Jeremy Amps; Mariano S Viapiano; Russell T Matthews; Michelle R Wagoner; Christopher M Whitaker; Warren Alilain; Alicia L Yonkof; Abdelnaby Khalyfa; Nigel G F Cooper; Jerry Silver; Stephen M Onifer
Journal:  Exp Neurol       Date:  2007-04-12       Impact factor: 5.330

5.  Aspiration of a cervical spinal contusion injury in preparation for delayed peripheral nerve grafting does not impair forelimb behavior or axon regeneration.

Authors:  Harra R Sandrow; Jed S Shumsky; Arthi Amin; John D Houle
Journal:  Exp Neurol       Date:  2007-12-15       Impact factor: 5.330

6.  Electrical stimulation of schwann cells promotes sustained increases in neurite outgrowth.

Authors:  Abigail N Koppes; Andrea L Nordberg; Gina M Paolillo; Nicole M Goodsell; Haley A Darwish; Linxia Zhang; Deanna M Thompson
Journal:  Tissue Eng Part A       Date:  2013-12-11       Impact factor: 3.845

7.  Effect of CLIP3 Upregulation on Astrocyte Proliferation and Subsequent Glial Scar Formation in the Rat Spinal Cord via STAT3 Pathway After Injury.

Authors:  Xiaoqing Chen; Cheng Chen; Jie Hao; Jiyun Zhang; Feng Zhang
Journal:  J Mol Neurosci       Date:  2017-12-07       Impact factor: 3.444

Review 8.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 9.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

10.  Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury.

Authors:  Philip J Johnson; Stanley R Parker; Shelly E Sakiyama-Elbert
Journal:  Biotechnol Bioeng       Date:  2009-12-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.